Search results for: Adrian Towse
Filter search results
The Future of Primary Care
1 January 1996
…of and solutions to low GP morale, by Professor Mant and Mr Towse. In the final chapter, Professor Roland sets out his vision as to how the dangers of fragmentation…
Improving Efficiency and Resource Allocation in Future Cancer Care
9 January 2016
…M., Welin, K-O., Bianchi, S., Althin, R., O’Neill, P., Persson, U., and Towse, A. (2016) Improving Efficiency and Resource Allocation in Future Cancer Care. OHE Contract Research. Available from https://www.ohe.org/publications/improving-efficiency-and-resource-allocation-future-cancer-care/…
Data Governance Arrangements for Real-World Evidence: South Korea
1 September 2017
…“ideal”, facilitative framework for data governance. 1 Cole, A., Garrison, L., Mestre-Ferrandiz, J., & Towse, A. (2015). Data Governance Arrangements for Real-World Evidence. OHE Consulting Report, London: Office of Health…
Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for Pharmaceutical Rebates
1 March 2019
…Towse, A., Segel C.S., Henshall, C., Pearson, S.D. Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for Pharmaceutical Rebates. Institute for Clinical and Economic Review and the…
Data Governance Arrangements for Real-World Evidence in Japan
1 September 2019
…Hideo Yasunaga and Hayato Yamana through desk research, using the same pre-specified pro-forma as for the previous reports. 1 Cole,A., Garrison,L., Mestre-Ferrandiz,J., Towse,A., 2015. Data Governance Arrangements for Real-World Evidence.OHE…
Cornerstones of “Fair” Drug Coverage: Appropriate Cost – Sharing and Utilization Management Policies for Pharmaceuticals
1 September 2020
…Pearson S, Lowe M, Towse A, Segel C, Henshall C. 2020. Cornerstones of “Fair” Drug Coverage: Appropriate Cost-Sharing and Utilization Management Policies for Pharmaceuticals. Institute for Clinical and Economic Review…
Resource Allocation in Public Sector Programmes: Does the Value of a Life Differ Between Governmental Departments?
1 February 2021
…decision making. OHE Consulting Report, London: Office of Health Economics. Available at: https://www.ohe.org/publications/international-cost-effectiveness-thresholds-and-modifiers-hta-decision-making Berdud M., Ferraro J., Towse A. 2020. A theory on ICER pricing and optimal level of cost-effectiveness…
Key Considerations for Early Access Schemes for Single-Administration (One-Time) Therapies
1 June 2021
…place. Acknowledgement: This report was commissioned by Novartis Gene Therapies. Citation Firth I., Schirrmacher H., Hampson G., Towse A. Key considerations for early access schemes for one-time therapies., London: Office…
Setting the Right Discount Rate for HTA in the Slovak Republic
21 May 2023
…containing the full set of recommendations and details of our analysis, click here. Citations Hitch J., Berdud M., Cubi-Molla P., Garau M., Towse A., 2023. Setting the right discount rate…